Chief Financial Officer · Lexeo Therapeutics, Inc. · Common Stock
Side
SELL
Value
$20K
Shares
4,117
Price
$4.91
Executed
Aug 18, 2026
Disclosed
Aug 19, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 18 executedAug 19, 2026 disclosed
LXEO · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Tamayo Louis Edward filed this Form 4 reporting a open-market sale of LXEO on Aug 18, 2026. It became public on Aug 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Tamayo Louis Edwardcik:0002083206
Issuer
Lexeo Therapeutics, Inc.cik:0001907108
Revision history · 0
No field has changed since this record was first ingested.
